|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization and depreciation | |||||
| Amortization of deferred issuance costs | |||||
| Stock-based compensation | |||||
| Fair value change in warrant liability | |||||
| Private placement warrant issuance costs reclassed to financing activities | |||||
| Loss on disposal of fixed assets | |||||
| Amortization of discounts and premiums on short-term investments | |||||
| Debt and equity facility costs reclassified to financing activities | |||||
| Non-cash lease expense | |||||
| Valuation adjustments for excess or obsolete inventory | |||||
| Change in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses, operating lease and other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Proceeds from the disposal of fixed assets | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of common stock in connection with public offerings and at-the-market offering program | |||||
| Issuance costs in connection with common stock issuances | |||||
| Proceeds from issuance of common stock in connection with private placement | |||||
| Proceeds from issuance of warrants in connection with private placement | |||||
| Proceeds from issuance of common stock in connection with at-the-market offering program | |||||
| Proceeds from issuance of common stock attributed to non-private placement equity offerings | |||||
| Issuance costs attributed to common stock and warrants issued in private placement | |||||
| Issuance costs related to non-private placement equity offerings | |||||
| Deferred issuance costs in connection with at-the-market offering program | |||||
| Deferred issuance costs in connection with debt facility | |||||
| Exercise of warrants | |||||
| Share repurchases for the payment of employee taxes | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental non-cash financing and investing transactions: | |||||
| Unpaid purchases of property and equipment | |||||
| Modification of right-of-use asset and associated lease liability | |||||
| Non-cash warrants issued in connection with debt facility | |||||
| Unpaid issuance costs in connection with private placement | |||||
| Unpaid deferred issuance costs | |||||
Loading...